PiggyBac Vector with mCMV Enhancer for Stable Protein Production
Solution Overview
Problem
Current methods for recombinant protein production in mammalian cells face challenges such as metabolic burden, which limits cellular productivity and stability of cell lines, especially when producing toxic proteins, leading to reduced growth rates and biomass accumulation.
Innovation Solution
A recombinant expression vector utilizing 5′ and 3′ PiggyBac transposon ITRs, combined with a mCMV enhancer and rat EF-1alpha intron sequences, and TetO sequences for inducible expression, to enhance genomic integration and promote stable, high-titer production of proteins like antibodies and hormones.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If higher levels of protein expression are achieved in mammalian cells, then productivity increases, but metabolic burden increases leading to reduced growth rate and biomass accumulation
Solution Approach 1:
The patent employs inducible expression systems that allow dynamic control of protein expression levels. The expression can be turned on or off based on cellular state, enabling high productivity when cells are healthy and preventing metabolic burden from overwhelming the system. This dynamic regulation resolves the contradiction by adapting expression levels to cellular capacity.
Solution Approach 2:
The patent utilizes systems where expression parameters can be changed - specifically using different promoters (CMV, EF-1α) with varying strengths and inducibility characteristics. By selecting or switching between promoters with appropriate expression levels, the system can optimize between productivity and cell health, resolving the contradiction through parameter adjustment.
2Productivity
If higher levels of protein expression are achieved in mammalian cells, then productivity increases, but growth rate decreases due to metabolic burden
Solution Approach 1:
The patent implements periodic or staged expression strategies where protein expression is induced at specific growth phases rather than continuously. This allows cells to grow and accumulate biomass during uninduced phases, then produce protein during induced phases, resolving the contradiction between growth rate and productivity through temporal separation.
Solution Approach 2:
By using inducible promoters that respond to environmental or genetic signals, the system dynamically adjusts expression levels based on cellular growth state. When growth rate is prioritized, expression remains low; when productivity is prioritized, expression is induced. This dynamic adaptation resolves the contradiction between growth speed and productivity.
3Productivity
If higher levels of protein expression are achieved in mammalian cells, then productivity increases, but biomass accumulation is reduced
Solution Approach 1:
The patent separates the culture process into distinct phases: a growth phase where cells accumulate biomass without protein expression, and a production phase where protein expression is induced. This segmentation allows biomass accumulation and productivity to occur at different times, resolving the contradiction between the two objectives.
Solution Approach 2:
The system employs periodic induction of expression after biomass accumulation, creating cycles of growth followed by production. This periodic action ensures that cells have sufficient biomass reserves before being induced to produce protein, resolving the contradiction between maintaining biomass and achieving high productivity.
4Reliability
If inducible expression systems are used to control protein production, then metabolic burden is reduced during cell growth, but additional control mechanisms and complexity are required
Solution Approach 1:
The patent uses intermediary molecules or genetic elements (such as tetracycline-responsive elements, cre-lox systems, or other inducible mechanisms) that mediate between the external induction signal and the expression machinery. This intermediary approach provides controlled induction while maintaining relatively simple vector and cell line construction, resolving the contradiction between reliability and complexity.
Data Source
AI summary
Recombinant expression vectors are disclosed that include a control sequence for recombinant expression of proteins of interest; the control sequence combines a mCMV enhancer sequence with a rat EF-1alpha intron sequence. Some of the vectors are useful for tetracycline-inducible expression. Some of the vectors contain a 5′ PiggyBac ITR and a 3′ PiggyBac ITR to promote genomic integration into a host cell chromosome. A method of selecting a stable production cell line for manufacturing a protein of interest is also disclosed. Also disclosed are mammalian host cells comprising the inventive recombinant expression vectors and a method of producing a protein of interest, in vitro, involving the mammalian host cell.